Benzinga | Mar 23, 2021 05:40AM EDT

SVB Leerink Maintains Market Perform on Ionis Pharmaceuticals, Lowers Price Target to $36

SVB Leerink analyst Mani Foroohar maintains Ionis Pharmaceuticals (NASDAQ:IONS) with a Market Perform and lowers the price target from $50 to $36.